SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001697884-20-000033
Filing Date
2020-12-15
Accepted
2020-12-14 17:43:18
Documents
43
Period of Report
2020-10-31

Document Format Files

Seq Description Document Type Size
1 vsbc10-qoctober2020.htm 10-Q 292115
2 vsbc10qoctober20202.gif GRAPHIC 181071
3 ex311.htm EX-31.1 20460
4 ex312.htm EX-31.2 20455
5 ex321.htm EX-32.1 6747
6 ex322.htm EX-32.2 6747
  Complete submission text file 0001697884-20-000033.txt   1602451

Data Files

Seq Description Document Type Size
7 none-20201031.xml EX-101.INS 206476
8 none-20201031.xsd EX-101.SCH 15514
9 none-20201031_cal.xml EX-101.CAL 2034
10 none-20201031_def.xml EX-101.DEF 14360
11 none-20201031_lab.xml EX-101.LAB 133638
12 none-20201031_pre.xml EX-101.PRE 75076
Mailing Address 2372 MORSE AVE. #950 IRVINE CA 92614
Business Address 2372 MORSE AVE. #950 IRVINE CA 92614 9492029235
VITASPRING BIOMEDICAL CO. LTD. (Filer) CIK: 0001697884 (see all company filings)

IRS No.: 371836726 | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 333-216465 | Film No.: 201387291
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services